Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hofseth Biocare ASA (GB:0Q6H)
LSE:0Q6H
Holding GB:0Q6H?
Track your performance easily
0Q6H Stock Chart & Stats
Day’s Rangekr0 - kr0
52-Week Rangekr2.16 - kr3.01
Previous Closekr2.16
Volume0.00
Average Volume (3M)N/A
Market Cap
kr554.96M
Enterprise Valuekr628.56M
Total Cash (Recent Filing)kr29.88M
Total Debt (Recent Filing)kr104.17M
Price to Earnings (P/E)―
Beta-0.40
Next Earnings
Feb 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.11
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)10.70
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hofseth Biocare ASA News
PremiumCompany Announcements
Hofseth Biocare ASA Shows Strong Revenue Growth
PremiumCompany Announcements
Hofseth Biocare’s Breakthrough in Prostate Cancer
PremiumCompany Announcements
Hofseth BioCare Reports Strong Quarterly Growth
PremiumCompany Announcements
Hofseth BioCare’s OmeGo® Aids COVID-19 Recovery
PremiumCompany Announcements
Hofseth BioCare Advances Eosinophil Drug CandidatePremiumCompany Announcements
Hofseth BioCare Strengthens Distribution in China
PremiumCompany Announcements
Hofseth BioCare ASA Celebrates Strong Q1 GrowthPremiumCompany Announcements
Hofseth BioCare Reports Strong Growth in Q1 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
0Q6H FAQ
What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest share price was kr2.16 and its highest was kr3.01 in the past 12 months.
What is Hofseth Biocare ASA’s market cap?
Currently, no data Available
When is Hofseth Biocare ASA’s upcoming earnings report date?
Hofseth Biocare ASA’s upcoming earnings report date is Feb 14, 2025 which is in 84 days.
How were Hofseth Biocare ASA’s earnings last quarter?
Hofseth Biocare ASA released its earnings results on Nov 08, 2024. The company reported -kr0.085 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.085.
Is Hofseth Biocare ASA overvalued?
According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued.
Does Hofseth Biocare ASA pay dividends?
Hofseth Biocare ASA does not currently pay dividends.
What is Hofseth Biocare ASA’s EPS estimate?
Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hofseth Biocare ASA have?
Hofseth Biocare ASA has 395,081,020 shares outstanding.
What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
Hofseth Biocare ASA reported an EPS of -kr0.085 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hofseth Biocare ASA?
Currently, no hedge funds are holding shares in GB:0Q6H
---
Hofseth Biocare ASA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-132.76%
Trailing 12-Months
Asset Growth
-8.19%
Trailing 12-Months
Company Description
Hofseth Biocare ASA
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium and nonwater soluble protein. The brands under the company are OmeGo, ProGo, and CalGo. The firm sells the products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.
---
Technical Analysis
---